Schopper Heather K, Stence Aaron, Ma Deqin, Pagedar Nitin A, Robinson Robert A
Department of Pathology, Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Otorhinolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
J Clin Pathol. 2017 Feb;70(2):116-119. doi: 10.1136/jclinpath-2016-203821. Epub 2016 Jul 7.
A 49-year-old man presented with a single thyroid tumour that showed a combination of conventional papillary carcinoma, follicular variant of papillary carcinoma, clear cell papillary carcinoma, columnar cell carcinoma and poorly differentiated carcinoma. As all of the morphologies have been associated with papillary carcinoma in the literature, we wished to determine if they contained identical or different molecular abnormalities.
Targeted next generation sequencing (NGS) of each morphological component and metastases was performed.
NGS revealed a BRAF p.K601E mutation in both the clear cell papillary carcinoma and poorly differentiated carcinoma and a KRAS p.G12R mutation in the papillary carcinoma, follicular variant. Two different areas of columnar cell variant were tested, with one showing a KRAS p.G12D mutation but no mutation in the other area. A KRAS p.G12R mutation was seen in the metastatic clear cell variant. Two different lymph nodes had metastatic columnar cell carcinoma, one negative for mutations but the other with a compound KRAS p.G12R and KRAS p.G12V mutation on different alleles. No mutations including BRAF and KRAS were seen in the conventional papillary carcinoma.
Although all of the morphological patterns in this tumour have been reported as having aetiological or other association with one another, there was only partial concordance with their molecular signatures. There was significant molecular discordance, however, even with identical morphologies.
一名49岁男性患者出现单个甲状腺肿瘤,其表现为传统乳头状癌、乳头状癌滤泡变体、透明细胞乳头状癌、柱状细胞癌和低分化癌的组合。由于文献中所有这些形态都与乳头状癌相关,我们希望确定它们是否包含相同或不同的分子异常。
对每个形态学成分和转移灶进行靶向二代测序(NGS)。
NGS显示透明细胞乳头状癌和低分化癌均存在BRAF p.K601E突变,乳头状癌滤泡变体存在KRAS p.G12R突变。对柱状细胞变体的两个不同区域进行检测,其中一个显示KRAS p.G12D突变,另一个区域未发现突变。在转移性透明细胞变体中发现KRAS p.G12R突变。两个不同的淋巴结有转移性柱状细胞癌,一个无突变,另一个在不同等位基因上有复合KRAS p.G12R和KRAS p.G12V突变。在传统乳头状癌中未发现包括BRAF和KRAS在内的突变。
尽管该肿瘤中的所有形态学模式在病因学或其他方面已被报道相互关联,但其分子特征仅部分一致。然而,即使形态相同,分子差异也很显著。